Loading...
Market
Which country outside the EU will first authorize Novavax's JN.1 vaccine by Mar 31, 2025?
2
Resolution / Starting Odds
United States • 25%
United Kingdom • 25%
Canada • 25%
Australia • 25%
Official announcements from national health authorities
Story
Novavax's Shares Rise as EU Authorizes Updated Nuvaxovid COVID-19 Vaccine Targeting JN.1 Strain
Oct 9, 2024, 12:30 PM
Novavax Inc.'s updated 2024-2025 Nuvaxovid COVID-19 vaccine has received authorization from the European Commission, the company announced on Wednesday. The vaccine, which targets the JN.1 strain of the coronavirus, is approved for preventing COVID-19 in individuals aged 12 years and older across the European Union. Following the news, Novavax's shares rose 3.2% in premarket trading.
View original story
Similar markets
United States • 25%
United Kingdom • 25%
Canada • 25%
Australia • 25%
United States • 25%
Canada • 25%
United Kingdom • 25%
Other • 25%
Yes • 50%
No • 50%
USA • 25%
Finland • 25%
Japan • 25%
Other EU country • 25%
Argentina • 25%
Mexico • 25%
India • 25%
Other • 25%
United States • 25%
European Union • 25%
Africa • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Australia • 25%
Other • 25%
China • 25%
India • 25%
Brazil • 25%
Other • 25%
Argentina • 25%
Mexico • 25%
India • 25%
Other • 25%
Canada • 25%
United Kingdom • 25%
Australia • 25%
Other • 25%
Yes • 50%
No • 50%